Nuveen Asset Management’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,079
| Closed | -$107K | – | 3338 |
|
|
2024
Q3 | $107K | Sell |
20,079
-25,802
| -56% | -$138K | ﹤0.01% | 3303 |
|
|
2024
Q2 | $339K | Buy |
+45,881
| New | +$339K | ﹤0.01% | 3118 |
|
|
2023
Q3 | – | Sell |
-29,948
| Closed | -$1.04M | – | 3204 |
|
|
2023
Q2 | $1.04M | Sell |
29,948
-12,835
| -30% | -$447K | ﹤0.01% | 2635 |
|
|
2023
Q1 | $933K | Buy |
42,783
+2,464
| +6% | +$53.7K | ﹤0.01% | 2638 |
|
|
2022
Q4 | $871K | Sell |
40,319
-1,444
| -3% | -$31.2K | ﹤0.01% | 2735 |
|
|
2022
Q3 | $1.02M | Buy |
41,763
+417
| +1% | +$10.2K | ﹤0.01% | 2743 |
|
|
2022
Q2 | $843K | Sell |
41,346
-5,895
| -12% | -$120K | ﹤0.01% | 2868 |
|
|
2022
Q1 | $1.92M | Buy |
47,241
+35,683
| +309% | +$1.45M | ﹤0.01% | 2524 |
|
|
2021
Q4 | $308K | Sell |
11,558
-1,428
| -11% | -$38.1K | ﹤0.01% | 3174 |
|
|
2021
Q3 | $625K | Buy |
12,986
+3,603
| +38% | +$173K | ﹤0.01% | 3124 |
|
|
2021
Q2 | $468K | Buy |
+9,383
| New | +$468K | ﹤0.01% | 3168 |
|